Clinical Trial

Impact of Probiotic (UltraFlora® Triplebiotic) on Weight Evolution on People After Discontinuation of GLP-1 Treatment.

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated October 6, 2025 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized, double-blind, double arm study involving 128 participants who will undergo a total participation period of 12 weeks.
Trial Details
NCT Number NCT07209046
Lead Sponsor Metagenics, Inc.
Conditions Adults, GLP-1
Enrollment 128 participants
Start Date 2025-11-01
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-07-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-06